Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Machleidt

Showing results (121-130 of 128) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 128 results.
European Journal of Clinical Investigation|April 15, 1999
Proteolytic destruction of functional proteins by phagocytes in human peritonitisM Jochum, A G Billing, D Fröhlich, et al.
Der Unfallchirurg|February 1, 1992
[Biochemical factors as objective parameters for assessing the prognosis in polytrauma]D Nast-Kolb, C Waydhas, M Jochum, et al.
The Journal of Biological Chemistry|July 27, 2000
A novel type of bifunctional inhibitor directed against proteolytic activity and receptor/ligand interaction. Cystatin with a urokinase receptor binding siteB Muehlenweg, I Assfalg-Machleidt, S G Parrado, et al.
The Biochemical Journal|May 15, 1986
Nomenclature and classification of the proteins homologous with the cysteine-proteinase inhibitor chicken cystatinA J Barrett, H Fritz, A Grubb, et al.
FEBS Letters|August 4, 1997
Quail cystatin: isolation and characterisation of a new member of the cystatin family and its hypothetical interaction with cathepsin BB Gerhartz, R A Engh, R Mentele, et al.
Biological Chemistry|March 22, 2001
Cystatins as calpain inhibitors: engineered chicken cystatin- and stefin B-kininogen domain 2 hybrids support a cystatin-like mode of interaction with the catalytic subunit of mu-calpainB G Díaz, S Gross, I Assfalg-Machleidt, et al.
The Plant Journal : for Cell and Molecular Biology|September 29, 2001
Phage display selection of hairpin loop soyacystatin variants that mediate high affinity inhibition of a cysteine proteinaseH Koiwa, M P D'Urzo, I Assfalg-Machleidt, et al.
Pharmacopsychiatry|March 30, 2012
Naturalistic pharmacotherapy of acute episodes of schizophrenic disorders in comparison to treatment guidelinesM Stein, D E Dietrich, M W Agelink, et al.
Pageof 13

Showing results (121-130 of 128) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 128 results.
European Journal of Clinical Investigation|April 15, 1999
Proteolytic destruction of functional proteins by phagocytes in human peritonitisM Jochum, A G Billing, D Fröhlich, et al.
Der Unfallchirurg|February 1, 1992
[Biochemical factors as objective parameters for assessing the prognosis in polytrauma]D Nast-Kolb, C Waydhas, M Jochum, et al.
The Journal of Biological Chemistry|July 27, 2000
A novel type of bifunctional inhibitor directed against proteolytic activity and receptor/ligand interaction. Cystatin with a urokinase receptor binding siteB Muehlenweg, I Assfalg-Machleidt, S G Parrado, et al.
The Biochemical Journal|May 15, 1986
Nomenclature and classification of the proteins homologous with the cysteine-proteinase inhibitor chicken cystatinA J Barrett, H Fritz, A Grubb, et al.
FEBS Letters|August 4, 1997
Quail cystatin: isolation and characterisation of a new member of the cystatin family and its hypothetical interaction with cathepsin BB Gerhartz, R A Engh, R Mentele, et al.
Biological Chemistry|March 22, 2001
Cystatins as calpain inhibitors: engineered chicken cystatin- and stefin B-kininogen domain 2 hybrids support a cystatin-like mode of interaction with the catalytic subunit of mu-calpainB G Díaz, S Gross, I Assfalg-Machleidt, et al.
The Plant Journal : for Cell and Molecular Biology|September 29, 2001
Phage display selection of hairpin loop soyacystatin variants that mediate high affinity inhibition of a cysteine proteinaseH Koiwa, M P D'Urzo, I Assfalg-Machleidt, et al.
Pharmacopsychiatry|March 30, 2012
Naturalistic pharmacotherapy of acute episodes of schizophrenic disorders in comparison to treatment guidelinesM Stein, D E Dietrich, M W Agelink, et al.
Pageof 13